Drug:
Reaction: MYELOSUPPRESSION
20250101 - 20251231
No. 1 - 100
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 1 | 25492061 |
CN |
61 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, |
||||
| 2 | 25492204 |
CN |
51 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, PERTUZUMAB, PERTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, TRASTUZUMAB, PACLITAXEL, PACLITAXEL, PACLITAXEL, CARBOPLATIN, CARBOPLATIN, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 3 | 25492306 |
CN |
54 | 2 |
Myelosuppression, Off label use, |
||||
PERTUZUMAB, TRASTUZUMAB, CARBOPLATIN, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 4 | 25492340 |
US |
75 | 2 |
Myelosuppression, |
||||
POMALIDOMIDE, HYDROCHLOROTHIAZIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, FERROUS SULFATE, ACYCLOVIR, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 5 | 25492411 |
CN |
50 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 6 | 25492542 |
CA |
41 | 2 |
Alopecia, Myelosuppression, Hepatotoxicity, Toxicity to various agents, Toxicity to various agents, Off label use, |
||||
METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, TRETINOIN, TRETINOIN, TRETINOIN, ARSENIC TRIOXIDE, ARSENIC TRIOXIDE, PREDNISONE, |
||||
| 7 | 25492653 |
CN |
49 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 8 | 25492754 |
CN |
41 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 9 | 25493019 |
CN |
48 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, |
||||
| 10 | 25493278 |
CN |
60 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PERTUZUMAB, |
||||
| 11 | 25493382 |
CN |
45 | 2 |
Myelosuppression, |
||||
| 12 | 25493388 |
CN |
59 | 2 |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, FAM-TRASTUZUMAB DERUXTECAN-NXKI, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 13 | 25493671 |
CN |
18 | 1 |
Coagulopathy, Myelosuppression, Febrile neutropenia, Drug resistance, |
||||
PREDNISONE, MITOXANTRONE HYDROCHLORIDE, MITOXANTRONE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 14 | 25493721 |
GB |
33 | 2 |
Myelosuppression, Off label use, |
||||
ETOPOSIDE, METHYLPREDNISOLONE, ANAKINRA, |
||||
| 15 | 25493928 |
CN |
67 | 2 |
Myelosuppression, Fatigue, Nausea, Vomiting, |
||||
LEUCOVORIN CALCIUM, OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 16 | 25494141 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 17 | 25494215 |
CN |
||
Myelosuppression, |
||||
CARBOPLATIN, ETOPOSIDE, |
||||
| 18 | 25494746 |
CN |
||
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 19 | 25494944 |
CN |
66 | 1 |
Myelosuppression, |
||||
PEMBROLIZUMAB, PEMETREXED, PEMETREXED DISODIUM, CISPLATIN, CISPLATIN, |
||||
| 20 | 25495181 |
CN |
31 | 1 |
Myelosuppression, Nausea, Vomiting, Asthenia, |
||||
CYTARABINE, IDARUBICIN HYDROCHLORIDE, |
||||
| 21 | 25495205 |
CN |
53 | 2 |
Myelosuppression, Hepatic function abnormal, |
||||
CRIZOTINIB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 22 | 25495257 |
CN |
67 | 1 |
Myelosuppression, Acute leukaemia, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 23 | 25495313 |
JP |
65 | 1 |
Myelosuppression, Drug eruption, |
||||
NECITUMUMAB, GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 24 | 25495347 |
CN |
70 | 1 |
Myelosuppression, |
||||
CETUXIMAB, IRINOTECAN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 25 | 25495353 |
CN |
65 | 2 |
Myelosuppression, |
||||
| 26 | 25496106 |
CN |
56 | 1 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Platelet count decreased, |
||||
CYTARABINE, |
||||
| 27 | 25496309 |
CN |
44 | 2 |
Myelosuppression, |
||||
PEMBROLIZUMAB, OXALIPLATIN, PACLITAXEL, |
||||
| 28 | 25496458 |
CN |
64 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 29 | 25496476 |
CN |
1 | |
Myelosuppression, |
||||
PEMETREXED, PEMETREXED DISODIUM, |
||||
| 30 | 25496487 |
CN |
67 | 2 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 31 | 25496515 |
CN |
76 | 2 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 32 | 25496537 |
CN |
48 | |
Myelosuppression, |
||||
PACLITAXEL, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 33 | 25496539 |
CN |
74 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, |
||||
| 34 | 25491460 |
CN |
74 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 35 | 25491484 |
US |
58 | 1 |
Myelosuppression, Increased tendency to bruise, Bronchiectasis, Infection, |
||||
VENETOCLAX, |
||||
| 36 | 25491557 |
CN |
52 | |
Myelosuppression, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 37 | 25489957 |
CN |
71 | 1 |
Myelosuppression, |
||||
TRASTUZUMAB, CAPECITABINE, CISPLATIN, CISPLATIN, CISPLATIN, CAPECITABINE, CAPECITABINE, TRASTUZUMAB, |
||||
| 38 | 25490112 |
CN |
46 | 1 |
Myelosuppression, Febrile neutropenia, Drug-induced liver injury, Hepatitis E, Hepatic failure, |
||||
FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB, BEVACIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, OXALIPLATIN, BEVACIZUMAB, OXALIPLATIN, |
||||
| 39 | 25490349 |
CN |
70 | 2 |
Myelosuppression, Intentional product use issue, |
||||
NIRAPARIB, |
||||
| 40 | 25486368 |
CN |
2 | |
Neurotoxicity, Myelosuppression, Alopecia, |
||||
PACLITAXEL, PEMBROLIZUMAB, |
||||
| 41 | 25486381 |
CN |
2 | |
Neurotoxicity, Myelosuppression, Alopecia, |
||||
PACLITAXEL, PEMBROLIZUMAB, |
||||
| 42 | 25486586 |
CN |
73 | |
Myelosuppression, Back pain, Productive cough, Diarrhoea, |
||||
ETOPOSIDE, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 43 | 25486598 |
CN |
42 | |
Myelosuppression, Pyrexia, |
||||
ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 44 | 25486609 |
JP |
6 | 1 |
Myelosuppression, Nausea, Protein total decreased, |
||||
ZOLBETUXIMAB, ZOLBETUXIMAB, |
||||
| 45 | 25486617 |
CN |
48 | 2 |
Myelosuppression, |
||||
GILTERITINIB, CLADRIBINE, VENETOCLAX, VENETOCLAX, CYTARABINE, |
||||
| 46 | 25486820 |
CN |
61 | |
Asthenia, Retching, Gastrooesophageal reflux disease, Oedema peripheral, Face oedema, Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, EPIRUBICIN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 47 | 25486926 |
CN |
52 | 2 |
Myelosuppression, |
||||
TRASTUZUMAB, PACLITAXEL, PERTUZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 48 | 25486943 |
CN |
47 | 2 |
Myelosuppression, |
||||
PERTUZUMAB, TRASTUZUMAB, DOCETAXEL, DOCETAXEL ANHYDROUS, CARBOPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 49 | 25487456 |
CN |
59 | 2 |
Myelosuppression, Pyrexia, Anger, Agitation, Apathy, Anaemia, Pallor, Breath sounds abnormal, Rales, Serum amyloid A protein increased, Blood glucose increased, Prealbumin decreased, Blood alkaline phosphatase decreased, Protein total decreased, Blood albumin decreased, Blood cholinesterase decreased, Blood urea increased, Cystatin C increased, Blood potassium decreased, Blood sodium increased, Blood chloride increased, Blood calcium decreased, Blood magnesium decreased, Blood phosphorus decreased, Interleukin level increased, Blood calcitonin increased, Activated partial thromboplastin time shortened, Blood fibrinogen decreased, Prothrombin time prolonged, Fibrin D dimer increased, Mucosal discolouration, |
||||
RITUXIMAB, POLATUZUMAB VEDOTIN, EPIRUBICIN HYDROCHLORIDE, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 50 | 25487825 |
CN |
59 | 1 |
Myelosuppression, Off label use, |
||||
GEMCITABINE HYDROCHLORIDE, CISPLATIN, |
||||
| 51 | 25487827 |
CN |
||
Myelosuppression, |
||||
CISPLATIN, |
||||
| 52 | 25487844 |
CN |
15 | 1 |
Myelosuppression, C-reactive protein increased, |
||||
DACTINOMYCIN, VINCRISTINE SULFATE, DEXAMETHASONE SODIUM PHOSPHATE, |
||||
| 53 | 25487895 |
CN |
3 | 2 |
Hyperpyrexia, Alopecia, Infection, Myelosuppression, |
||||
DACTINOMYCIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DACTINOMYCIN, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, |
||||
| 54 | 25488779 |
CN |
56 | 2 |
Myelosuppression, |
||||
| 55 | 25488827 |
JP |
82 | 2 |
Myelodysplastic syndrome with excess blasts, Folate deficiency, Myelosuppression, |
||||
FOLIC ACID, AMLODIPINE BESYLATE, LOSARTAN POTASSIUM, LOSARTAN, MAGNESIUM OXIDE, ESZOPICLONE, AMLODIPINE, CEFAZOLIN SODIUM, FILGRASTIM, FUROSEMIDE, DARBEPOETIN ALFA, |
||||
| 56 | 25488865 |
CN |
43 | 1 |
Myelosuppression, |
||||
CRIZOTINIB, |
||||
| 57 | 25489069 |
CN |
58 | 2 |
Myelosuppression, White blood cell count decreased, Pyrexia, |
||||
PERTUZUMAB, |
||||
| 58 | 25489582 |
CN |
43 | |
Myelosuppression, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, CISPLATIN, CISPLATIN, |
||||
| 59 | 25489600 |
CN |
66 | 2 |
Myelosuppression, |
||||
FAM-TRASTUZUMAB DERUXTECAN-NXKI, WATER, STERILE WATER, STERILE WATER FOR INJECTION, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 60 | 25489605 |
CN |
61 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PACLITAXEL, PACLITAXEL, |
||||
| 61 | 25489786 |
CN |
75 | 2 |
Myelosuppression, Lipids increased, Oedema peripheral, |
||||
LORLATINIB, |
||||
| 62 | 25489787 |
CN |
56 | 1 |
Myelosuppression, Platelet count decreased, Pyrexia, Cardiac disorder, Tachypnoea, Condition aggravated, |
||||
CYTARABINE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 63 | 25489788 |
CN |
11 | 1 |
Myelosuppression, Blood bilirubin increased, Bilirubin conjugated increased, Blood bilirubin unconjugated increased, Protein total decreased, Blood albumin decreased, Globulins decreased, Alanine aminotransferase increased, Aspartate aminotransferase increased, |
||||
CYTARABINE, |
||||
| 64 | 25489790 |
CN |
59 | 1 |
Myelosuppression, Infection, Rash erythematous, Tongue blistering, |
||||
CYTARABINE, |
||||
| 65 | 25489808 |
CN |
36 | |
Myelosuppression, |
||||
OXALIPLATIN, OXALIPLATIN, CAPECITABINE, CAPECITABINE, |
||||
| 66 | 25489843 |
CN |
69 | 1 |
Asthenia, Inappropriate schedule of product administration, Myelosuppression, |
||||
PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 67 | 25489900 |
CN |
48 | 2 |
Myelosuppression, |
||||
SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 68 | 25490414 |
CN |
53 | 1 |
Myelosuppression, |
||||
CETUXIMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 69 | 25490459 |
CN |
70 | 2 |
Myelosuppression, |
||||
PRALSETINIB, |
||||
| 70 | 25481104 |
CN |
57 | 2 |
Myelosuppression, |
||||
VENETOCLAX, WATER, STERILE WATER, STERILE WATER FOR INJECTION, AZACITIDINE, AZACITIDINE FOR, |
||||
| 71 | 25481223 |
CN |
59 | |
Myelosuppression, |
||||
CARBOPLATIN, CARBOPLATIN, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, |
||||
| 72 | 25481278 |
CN |
59 | |
Myelosuppression, |
||||
PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, PEMETREXED DISODIUM, PEMETREXED, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, BEVACIZUMAB, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 73 | 25481355 |
CN |
3 | 1 |
Blood fibrinogen decreased, Myelosuppression, White blood cell count decreased, Neutrophil count decreased, Red blood cell count decreased, Platelet count decreased, Haemoglobin decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MERCAPTOPURINE, METHOTREXATE, METHOTREXATE SODIUM, CYTARABINE, |
||||
| 74 | 25481490 |
CN |
59 | |
Fatigue, Decreased appetite, Myelosuppression, |
||||
| 75 | 25481620 |
PL |
6 | 1 |
Juvenile chronic myelomonocytic leukaemia, Neoplasm progression, Multiple organ dysfunction syndrome, Pneumonia, Leukaemia recurrent, Acute myeloid leukaemia, Drug ineffective, Condition aggravated, Myelosuppression, Off label use, Infection, |
||||
AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, CYTARABINE, CYTARABINE, CYTARABINE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, FLUDARABINE PHOSPHATE, MERCAPTOPURINE, MERCAPTOPURINE, BUSULFAN, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, MELPHALAN, MELPHALAN HYDROCHLORIDE, |
||||
| 76 | 25481739 |
CN |
70 | |
Myelosuppression, |
||||
ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, ETOPOSIDE, CISPLATIN, CISPLATIN, CISPLATIN, CISPLATIN, |
||||
| 77 | 25481776 |
CN |
56 | 2 |
Myelosuppression, White blood cell count decreased, Neutrophil count decreased, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 78 | 25481831 |
CN |
77 | 2 |
Myelosuppression, |
||||
BEVACIZUMAB, CAPECITABINE, OXALIPLATIN, |
||||
| 79 | 25481868 |
CN |
55 | |
Myelosuppression, Nausea, Vomiting, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE HYDROCHLORIDE, |
||||
| 80 | 25482614 |
ES |
26 | 2 |
Graft versus host disease in skin, Bronchopulmonary aspergillosis, Febrile neutropenia, Myelosuppression, Asthenia, Drug ineffective, Localised infection, Paronychia, |
||||
QUIZARTINIB, CYTARABINE, CYTARABINE, FILGRASTIM, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, AZACITIDINE, AZACITIDINE FOR, FLUDARABINE PHOSPHATE, VENETOCLAX, VENETOCLAX, VENETOCLAX, VENETOCLAX, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, |
||||
| 81 | 25482908 |
CN |
37 | 2 |
Myelosuppression, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, DEXTROSE MONOHYDRATE, DEXTROSE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, PACLITAXEL, PACLITAXEL, PACLITAXEL, PACLITAXEL, |
||||
| 82 | 25482957 |
54 | 2 | |
Prescription drug used without a prescription, Pancytopenia, Stomatitis, Myelosuppression, Toxicity to various agents, Idiosyncratic drug reaction, |
||||
METHOTREXATE, METHOTREXATE SODIUM, ETANERCEPT, PREDNISONE, |
||||
| 83 | 25483289 |
JP |
51 | 1 |
Anaemia, Tumour haemorrhage, Myelosuppression, |
||||
PEMBROLIZUMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, CISPLATIN, |
||||
| 84 | 25483345 |
CN |
||
Myelosuppression, |
||||
CISPLATIN, GEMCITABINE HYDROCHLORIDE, |
||||
| 85 | 25483346 |
CN |
||
Myelosuppression, |
||||
PACLITAXEL, |
||||
| 86 | 25483751 |
CN |
55 | 2 |
Myelosuppression, |
||||
SACITUZUMAB GOVITECAN, |
||||
| 87 | 25484092 |
JP |
57 | 2 |
Pneumocystis jirovecii pneumonia, Hypertension, Myelosuppression, Alanine aminotransferase increased, Gamma-glutamyltransferase increased, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
| 88 | 25485347 |
CN |
74 | 1 |
Myelosuppression, Anaemia, Platelet count abnormal, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 89 | 25485365 |
JP |
6 | 2 |
Myelosuppression, Immune-mediated cholangitis, Skin disorder, Irritability, Thyroid disorder, Hypertension, Palmar-plantar erythrodysaesthesia syndrome, Arthralgia, Myalgia, Middle insomnia, Stomatitis, Decreased appetite, Weight decreased, Hepatic enzyme increased, |
||||
PEMBROLIZUMAB, |
||||
| 90 | 25485434 |
US |
82 | 2 |
Myelosuppression, Platelet count decreased, Therapeutic response unexpected, Fatigue, Nausea, White blood cell count decreased, Decreased appetite, Hair growth abnormal, Procedural pain, Product dose omission in error, |
||||
PALBOCICLIB, METOPROLOL TARTRATE, METOPROLOL, LEVOTHYROXINE, FULVESTRANT, |
||||
| 91 | 25485455 |
JP |
8 | 1 |
Myelosuppression, Febrile neutropenia, |
||||
ZOLBETUXIMAB, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, LEVOLEUCOVORIN INJECTION, LEVOLEUCOVORIN CALCIUM, LEVOLEUCOVORIN, OXALIPLATIN, |
||||
| 92 | 25485641 |
CN |
64 | 2 |
Myelosuppression, Underdose, Off label use, |
||||
GILTERITINIB, CYTARABINE, VENETOCLAX, |
||||
| 93 | 25486157 |
CN |
47 | 1 |
Myelosuppression, |
||||
VENETOCLAX, AZACITIDINE, AZACITIDINE FOR, |
||||
| 94 | 25486215 |
CN |
80 | |
Myelosuppression, Nausea, |
||||
| 95 | 25486229 |
CN |
61 | |
Myelosuppression, |
||||
OXALIPLATIN, FLUOROURACIL CREAM, 0.5%, FLUOROURACIL, |
||||
| 96 | 25486244 |
CN |
69 | |
Myelosuppression, Pyrexia, |
||||
PACLITAXEL, PACLITAXEL, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 97 | 25486246 |
CN |
67 | |
Myelosuppression, Hepatitis B, |
||||
| 98 | 25486281 |
CN |
59 | |
Myelosuppression, |
||||
PACLITAXEL, PACLITAXEL, CISPLATIN, CISPLATIN, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
| 99 | 25486290 |
CN |
71 | 1 |
Myelosuppression, |
||||
VENETOCLAX, |
||||
| 100 | 25486299 |
CN |
74 | |
Myelosuppression, |
||||
IRINOTECAN HYDROCHLORIDE, IRINOTECAN HYDROCHLORIDE, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, SODIUM CHLORIDE, SODIUM CHLORIDE INJECTION, SODIUM CHLORIDE TABLET, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-07-29